Introduction
A hallmark of systemic autoimmune diseases like systemic lupus erythematosus (SLE) is the increased expression of interferon (IFN) type I inducible genes, so-called IFN type I signature. Recently, T-helper 17 subset (Th17 cells), which produces IL-17A, IL-17F, IL-21, and IL-22, has been implicated in SLE. As CCR6 enriches for Th17 cells, we used this approach to investigate whether CCR6
+ memory T-helper cells producing IL-17A, IL-17F, IL-21, and/or IL-22 are increased in SLE patients and whether this increase is related to the presence of IFN type I signature.
Methods
In total, 25 SLE patients and 15 healthy controls (HCs) were included. SLE patients were divided into IFN type I signature-positive (IFN
+) (
n = 16) and negative (IFN
-) (
n = 9) patients, as assessed by mRNA expression of IFN-inducible genes (IFIGs) in monocytes. Expression of IL-17A, IL-17F, IL-21, and IL-22 by CD4
+CD45RO
+CCR6
+ T cells (CCR6
+ cells) was measured with flow cytometry and compared between IFN
+, IFN
- patients and HCs.
Results
Increased percentages of IL-17A and IL-17A/IL-17F double-producing CCR6
+ cells were observed in IFN
+ patients compared with IFN
- patients and HCs. IL-17A and IL-17F expression within CCR6
+ cells correlated significantly with IFIG expression. In addition, we found significant correlation between B-cell activating factor of the tumor necrosis family (
BAFF)–a factor strongly correlating with IFN type I - and IL-21 producing CCR6
+ cells.
Conclusions
We show for the first time higher percentages of IL-17A and IL-17A/IL-17F double-producing CCR6
+ memory T-helper cells in IFN
+ SLE patients, supporting the hypothesis that IFN type I co-acts with Th17 cytokines in SLE pathogenesis.
相似文献